NASDAQ: PRQR
Proqr Therapeutics Nv Stock Ownership - Who owns Proqr Therapeutics Nv?

Insider buying vs selling

Have Proqr Therapeutics Nv insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when PRQR insiders and whales buy or sell their stock.

PRQR Shareholders

What type of owners hold Proqr Therapeutics Nv stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Adage Capital Partners GP LLC5.81%6,253,467$10.13MInstitution
Privium Fund Management Bv4.64%4,998,287$8.10MInstitution
Affinity Asset Advisors LLC3.34%3,600,000$5.83MInstitution
Morgan Stanley2.69%2,901,202$4.70MInstitution
Aberdeen Group PLC2.13%2,298,823$3.72MInstitution
Sio Capital Management LLC1.93%2,075,139$3.36MInstitution
Kynam Capital Management LP1.53%1,649,462$2.67MInstitution
Dafna Capital Management LLC1.46%1,567,561$2.54MInstitution
Siren LLC1.44%1,552,183$2.51MInstitution
Arrowmark Colorado Holdings LLC1.16%1,246,234$2.02MInstitution

1 of 3

PRQR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PRQR34.86%0.00%
CAMP52.04%47.96%Net Buying
ZNTL62.97%37.03%Net SellingNet Selling
CGEN13.31%0.00%
RNAC12.77%87.23%Net BuyingNet Buying

Proqr Therapeutics Nv Stock Ownership FAQ

Who owns Proqr Therapeutics Nv?

Proqr Therapeutics Nv (NASDAQ: PRQR) is owned by 34.86% institutional shareholders, 0.00% Proqr Therapeutics Nv insiders, and 65.14% retail investors. Adage Capital Partners GP LLC is the largest individual Proqr Therapeutics Nv shareholder, owning 6.25M shares representing 5.81% of the company. Adage Capital Partners GP LLC's Proqr Therapeutics Nv shares are currently valued at $10.13M.

If you're new to stock investing, here's how to buy Proqr Therapeutics Nv stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.